We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Sustained SIV Remission Achieved in Monkeys

News   Oct 26, 2016

 
Sustained SIV Remission Achieved in Monkeys
 
 
Advertisement
 

RELATED ARTICLES

Delaying Second COVID-19 Vaccine Dose May Prevent Deaths, Under Certain Conditions

News

A study has found that delaying the second dose of covid-19 vaccines, at least for people aged under 65, could result in up to 20% lower mortality, but only under certain conditions.

READ MORE

Skin-Patch Vaccine for Dengue Fever Successful in Preclinical Models

News

A dengue virus vaccine candidate has shown promising results in animal models, producing a protective immune response in dengue-infected mice.

READ MORE

Preclinical Study Finds NK Cells Show Activity Against Lymphoma Cells

News

According to a new preclinical study, cytokine-activated natural killer (NK) cells combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE